Phase II-IIIb

ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – IIIb trials.

Post-Approval Research


ICON can provide advice and operational support for clinical and commercial activities after drug registration in the following areas:

  • Product Registries
  • Community Surveys
  • Epidemiologic Studies and prospective Disease Registries
  • Safety Surveillance
  • Retrospective Chart Reviews
  • Post-Hoc Analysis of Registration Studies
  • Administrative Claims Analyses 
  • Reimbursement Support
  • Decision-Analytic Models
  • Comparative Effectiveness Studies
  • Non-interventional Phase IV Clinical Trials
  • Educational Interventions for Providers or Patients